To Order: patrick@cotinis.com
LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody |
|||
| ABP56962-01ml | Abbkine | 0.1ml | EUR 289 |
|
Description: A polyclonal antibody for detection of LATS1/2 phospho Thr1079/1041) from Human, Mouse. This LATS1/2 phospho Thr1079/1041) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the phosphorylation site of T1079/1041 |
|||
LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody |
|||
| ABP56962-02ml | Abbkine | 0.2ml | EUR 414 |
|
Description: A polyclonal antibody for detection of LATS1/2 phospho Thr1079/1041) from Human, Mouse. This LATS1/2 phospho Thr1079/1041) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the phosphorylation site of T1079/1041 |
|||
LATS1/2 (Phospho-Thr1079/1041) Polyclonal Antibody |
|||
| ABP59095-003ml | Abbkine | 0.03ml | EUR 158 |
|
Description: A polyclonal antibody for detection of LATS1/2 Phospho-Thr1079/1041) from Human, Mouse, Rat. This LATS1/2 Phospho-Thr1079/1041) antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 (Phospho-Thr1079/1041) Antibody protein |
|||
LATS1/2 (Phospho-Thr1079/1041) Polyclonal Antibody |
|||
| ABP59095-01ml | Abbkine | 0.1ml | EUR 289 |
|
Description: A polyclonal antibody for detection of LATS1/2 Phospho-Thr1079/1041) from Human, Mouse, Rat. This LATS1/2 Phospho-Thr1079/1041) antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 (Phospho-Thr1079/1041) Antibody protein |
|||
LATS1/2 (Phospho-Thr1079/1041) Polyclonal Antibody |
|||
| ABP59095-02ml | Abbkine | 0.2ml | EUR 414 |
|
Description: A polyclonal antibody for detection of LATS1/2 Phospho-Thr1079/1041) from Human, Mouse, Rat. This LATS1/2 Phospho-Thr1079/1041) antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 (Phospho-Thr1079/1041) Antibody protein |
|||
Anti-Phospho-LATS1/2 (Thr1079/1041) antibody |
|||
| STJ99599 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Phospho-LATS1/2 (Thr1079/1041). |
|||
Phospho-LATS1/LATS2 (Thr1079/1041) Antibody |
|||
| CSB-PA905508- | Cusabio | EUR 335 | |
|
Description: A polyclonal antibody against Phospho-LATS1/LATS2 (Thr1079/1041). Recognizes Phospho-LATS1/LATS2 (Thr1079/1041) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100 |
|||
Phospho-LATS1/LATS2 (Thr1079/1041) Antibody |
|||
| CSB-PA905508-100ul | Cusabio | 100ul | EUR 362 |
|
Description: A polyclonal antibody against Phospho-LATS1/LATS2 (Thr1079/1041). Recognizes Phospho-LATS1/LATS2 (Thr1079/1041) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100 |
|||
LATS1/2 (Phospho-Thr1079/1041) Polyclonal Conjugated Antibody |
|||
| C11736 | SAB | 100ul | EUR 397 |
LATS1 (Phospho-Thr1079) Antibody |
|||
| 13032-100ul | SAB | 100ul | EUR 252 |
LATS1 (Phospho-Thr1079) Antibody |
|||
| 13032-50ul | SAB | 50ul | EUR 187 |
Phospho-LATS1 (Thr1079) Antibody |
|||
| AF7169 | Affbiotech | 200ul | EUR 376 |
|
Description: Phospho-LATS1 (Thr1079) Antibody detects endogenous levels of LATS1 only when phosphorylated at Thr1079. |
|||
Phospho- LATS1 (Thr1079) Antibody |
|||
| ABF3638 | Lifescience Market | 100 ug | EUR 438 |
LATS1 (Phospho-Thr1079) Conjugated Antibody |
|||
| C13032 | SAB | 100ul | EUR 397 |
Phospho-LATS1 (Thr1079) Blocking Peptide |
|||
| AF7169-BP | Affbiotech | 1mg | EUR 195 |
LATS antibody (Thr1079/1041) |
|||
| 70R-32663 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal LATS antibody (Thr1079/1041) |
|||
Anti-Phospho-LATS1/2 (T1079/1041) antibody |
|||
| STJ91207 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Phospho-LATS1/2 (T1079/1041). |
|||
Phospho-LATS1/LATS2 (T1079/1041) Antibody |
|||
| 1-CSB-PA070231 | Cusabio |
|
|
|
Description: A polyclonal antibody against Phospho-LATS1/LATS2 (T1079/1041). Recognizes Phospho-LATS1/LATS2 (T1079/1041) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/20000 |
|||
LATS1 / LATS2 (pT1079 / 1041) Antibody |
|||
| abx332955-100ul | Abbexa | 100 ul | EUR 467 |
LATS1 / LATS2 (pT1079 / 1041) Antibody |
|||
| 20-abx325183 | Abbexa |
|
|
Anti-LATS1 Antibody |
|||
| A01051-2 | BosterBio | 100ug/vial | EUR 334 |
LATS1/2 (Phospho-Ser909/872) Antibody |
|||
| 12514-100ul | SAB | 100ul | EUR 252 |
LATS1/2 (Phospho-Ser909/872) Antibody |
|||
| 12514-50ul | SAB | 50ul | EUR 187 |
Phospho-LATS1/2 (Ser909/872) Antibody |
|||
| AF8163 | Affbiotech | 200ul | EUR 376 |
|
Description: LATS1/2 (Phospho-Ser909/872) Antibody detects endogenous levels of LATS1/2 only when phosphorylated at Ser909/872. |
|||
LATS1/2 (Phospho- Ser909/872) Antibody |
|||
| ABF8163 | Lifescience Market | 100 ug | EUR 438 |
LATS1 (Phospho-Ser909) Antibody |
|||
| 13033-100ul | SAB | 100ul | EUR 252 |
LATS1 (Phospho-Ser909) Antibody |
|||
| 13033-50ul | SAB | 50ul | EUR 187 |
LATS1 (Phospho-Tyr283) Antibody |
|||
| 13034-100ul | SAB | 100ul | EUR 252 |
LATS1 (Phospho-Tyr283) Antibody |
|||
| 13034-50ul | SAB | 50ul | EUR 187 |
Phospho-LATS1 (Ser909) Antibody |
|||
| AF7170 | Affbiotech | 200ul | EUR 376 |
|
Description: Phospho-LATS1 (Ser909) Antibody detects endogenous levels of LATS1 only when phosphorylated at Ser909. |
|||
Phospho-LATS1 (Tyr283) Antibody |
|||
| AF7171 | Affbiotech | 200ul | EUR 376 |
|
Description: Phospho-LATS1 (Tyr283) Antibody detects endogenous levels of LATS1 only when phosphorylated at Tyr283. |
|||
LATS1/2 Antibody |
|||
| 33232-100ul | SAB | 100ul | EUR 252 |
LATS1/2 Antibody |
|||
| 33232-50ul | SAB | 50ul | EUR 187 |
lats1/2 Antibody |
|||
| DF7517 | Affbiotech | 200ul | EUR 304 |
|
Description: lats1 Antibody detects endogenous levels of total lats1/2. |
|||
LATS1 (Phospho-Ser909) Conjugated Antibody |
|||
| C13033 | SAB | 100ul | EUR 397 |
LATS1 (Phospho-Tyr283) Conjugated Antibody |
|||
| C13034 | SAB | 100ul | EUR 397 |
LATS1/2 (Phospho-Ser909/872) Polyclonal Conjugated Antibody |
|||
| C12514 | SAB | 100ul | EUR 397 |
Serine/threonine-Protein Kinase LATS1/2 (LATS1/2) Antibody |
|||
| 20-abx141092 | Abbexa |
|
|
Serine/threonine-Protein Kinase LATS1/2 (LATS1/2) Antibody |
|||
| 20-abx012918 | Abbexa |
|
|
Phospho-LATS1/2 (Ser909/872) Blocking Peptide |
|||
| AF8163-BP | Affbiotech | 1mg | EUR 195 |
LATS1/2 Polyclonal Antibody |
|||
| ES2704-50ul | ELK Biotech | 50ul | EUR 207 |
|
Description: A Rabbit Polyclonal antibody against LATS1/2 from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
LATS1/2 Polyclonal Antibody |
|||
| ES2704-100ul | ELK Biotech | 100ul | EUR 279 |
|
Description: A Rabbit Polyclonal antibody against LATS1/2 from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
Anti-LATS1/2 Antibody |
|||
| A01051 | BosterBio | 100ul | EUR 397 |
|
Description: Rabbit Polyclonal LATS1/2 Antibody. Validated in IHC and tested in Human. |
|||
Anti-LATS1/2 Antibody |
|||
| A01051-1 | BosterBio | 100ul | EUR 397 |
|
Description: Rabbit Polyclonal Antibody for LATS1/2 Antibody (LATS1) detection.tested for WB in Human, Mouse. |
|||
LATS1/2 Polyclonal Antibody |
|||
| ABP51705-003ml | Abbkine | 0.03ml | EUR 158 |
|
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse. This LATS1/2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the non-phosphorylation site of T1079/1041 |
|||
LATS1/2 Polyclonal Antibody |
|||
| ABP51705-01ml | Abbkine | 0.1ml | EUR 289 |
|
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse. This LATS1/2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the non-phosphorylation site of T1079/1041 |
|||
LATS1/2 Polyclonal Antibody |
|||
| ABP51705-02ml | Abbkine | 0.2ml | EUR 414 |
|
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse. This LATS1/2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the non-phosphorylation site of T1079/1041 |
|||
LATS1/2 Polyclonal Antibody |
|||
| ABP59096-003ml | Abbkine | 0.03ml | EUR 158 |
|
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse, Rat. This LATS1/2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 antibody protein |
|||
LATS1/2 Polyclonal Antibody |
|||
| ABP59096-01ml | Abbkine | 0.1ml | EUR 289 |
|
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse, Rat. This LATS1/2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 antibody protein |
|||
LATS1/2 Polyclonal Antibody |
|||
| ABP59096-02ml | Abbkine | 0.2ml | EUR 414 |
|
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse, Rat. This LATS1/2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 antibody protein |
|||
Anti-LATS1/2 antibody |
|||
| STJ93908 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to LATS1/2. |
|||
Anti-LATS1/2 antibody |
|||
| STJ99623 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to LATS1/2. |
|||
LATS1/2 Conjugated Antibody |
|||
| C33232 | SAB | 100ul | EUR 397 |
Phospho-LATS1 (Ser909) Blocking Peptide |
|||
| AF7170-BP | Affbiotech | 1mg | EUR 195 |
Phospho-LATS1 (Tyr283) Blocking Peptide |
|||
| AF7171-BP | Affbiotech | 1mg | EUR 195 |
LATS1 Antibody |
|||
| 1-CSB-PA830665 | Cusabio |
|
|
|
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100 |
|||
LATS1 Antibody |
|||
| 1-CSB-PA012769GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
|||
LATS1 Antibody |
|||
| 1-CSB-PA012769LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF, IP; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:500, IP:1:200-1:2000 |
|||
LATS1 Antibody |
|||
| 36187-100ul | SAB | 100ul | EUR 252 |
LATS1 Antibody |
|||
| AF7669 | Affbiotech | 200ul | EUR 376 |
|
Description: LATS1 Antibody detects endogenous levels of LATS1. |
|||
LATS1 Antibody |
|||
| AF7670 | Affbiotech | 200ul | EUR 376 |
|
Description: LATS1 Antibody detects endogenous levels of LATS1. |
|||
LATS1 Antibody |
|||
| AF7671 | Affbiotech | 200ul | EUR 376 |
|
Description: LATS1 Antibody detects endogenous levels of LATS1. |
|||
lats1 Antibody |
|||
| ABD7517 | Lifescience Market | 100 ug | EUR 438 |
LATS1 antibody |
|||
| 70R-18222 | Fitzgerald | 50 ul | EUR 435 |
|
Description: Rabbit polyclonal LATS1 antibody |
|||
LATS1 antibody |
|||
| 70R-5683 | Fitzgerald | 50 ug | EUR 467 |
|
Description: Rabbit polyclonal LATS1 antibody |
|||
LATS1 antibody |
|||
| 70R-51351 | Fitzgerald | 100 ul | EUR 244 |
|
Description: Purified Polyclonal LATS1 antibody |
|||
LATS1 / 2 (pS909 / 872) Antibody |
|||
| abx216529-100ug | Abbexa | 100 ug | EUR 439 |
Anti-phospho-LATS1-S909/LATS2-S872 antibody |
|||
| STJ11101017 | St John's Laboratory | 50 µl | EUR 393 |
|
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
Anti-phospho-LATS1-T1079/LATS2-T1041 antibody |
|||
| STJ11101018 | St John's Laboratory | 50 µl | EUR 393 |
|
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
Anti-phospho-LATS1-S909/LATS2-S872 antibody |
|||
| STJ11101039 | St John's Laboratory | 100 µl | EUR 393 |
|
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
Anti-phospho-LATS1-T1079/LATS2-T1041 antibody |
|||
| STJ11101047 | St John's Laboratory | 100 µl | EUR 393 |
|
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC041041-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF405S conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC041041-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF405S conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC471041-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF647 conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC471041-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF647 conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNCAP1041-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNCAP1041-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNCB1041-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), Biotin conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNCB1041-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), Biotin conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC811041-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF680R conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC811041-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF680R conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC701041-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF770 conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC701041-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF770 conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC881041-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF488A conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC881041-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF488A conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC611041-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC611041-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC681041-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF568 conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC681041-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF568 conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNCA1041-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), APC conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNUM1041-50 | Biotium | 50uL | EUR 395 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), 1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC051041-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC051041-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNCP1041-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), PerCP conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNCR1041-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), RPE conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNUB1041-100 | Biotium | 100uL | EUR 209 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), Concentration: 0.2mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNUB1041-500 | Biotium | 500uL | EUR 458 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), Concentration: 0.2mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC431041-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC431041-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNCH1041-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNCH1041-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC551041-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC551041-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC941041-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF594 conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC941041-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF594 conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC801041-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF680 conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC801041-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF680 conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC401041-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TRIM29(TRIM29/1041) Antibody |
|||
| BNC401041-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against TRIM29(TRIM29/1041), CF640R conjugate, Concentration: 0.1mg/mL |
|||
LATS1 / 2 Blocking Peptide |
|||
| 20-abx061790 | Abbexa |
|
|
lats1/2 Blocking Peptide |
|||
| DF7517-BP | Affbiotech | 1mg | EUR 195 |
Human/Monkey Anti-Chick Type I Collagen IgA Antibody Assay Kit, (OPD) |
|||
| 1041 | Chondrex | 1 kit | EUR 628.55 |
|
Description: Human/Monkey Anti-Chick Type I Collagen IgA Antibody Assay Kit |
|||
LATS1/LATS2 Antibody |
|||
| 1-CSB-PA003141 | Cusabio |
|
|
|
Description: A polyclonal antibody against LATS1/LATS2. Recognizes LATS1/LATS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;IHC:1/100-1/300.ELISA:1/40000 |
|||
LATS1/LATS2 Antibody |
|||
| CSB-PA069135- | Cusabio | EUR 335 | |
|
Description: A polyclonal antibody against LATS1/LATS2. Recognizes LATS1/LATS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100 |
|||
LATS1/LATS2 Antibody |
|||
| CSB-PA069135-100ul | Cusabio | 100ul | EUR 316 |
|
Description: A polyclonal antibody against LATS1/LATS2. Recognizes LATS1/LATS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100 |
|||
Anti-LATS1 antibody |
|||
| STJ119966 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
Anti-LATS1 antibody |
|||
| STJ11100931 | St John's Laboratory | 100 µl | EUR 393 |
|
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. |
|||
LATS1 / LATS2 Antibody |
|||
| abx331369-100ul | Abbexa | 100 ul | EUR 425 |
LATS1 / LATS2 Antibody |
|||
| 20-abx325262 | Abbexa |
|
|
LATS1 Conjugated Antibody |
|||
| C36187 | SAB | 100ul | EUR 397 |
anti- LATS1 antibody |
|||
| FNab04708 | FN Test | 100µg | EUR 505.25 |
|
Description: Antibody raised against LATS1 |
|||
Anti-LATS1 antibody |
|||
| PAab04708 | Lifescience Market | 100 ug | EUR 355 |
phospho-LATS1-S909/LATS2-S872 Rabbit pAb |
|||
| AP0879-100ul | Abclonal | 100 ul | Ask for price |
phospho-LATS1-S909/LATS2-S872 Rabbit pAb |
|||
| AP0879-200ul | Abclonal | 200 ul | Ask for price |
phospho-LATS1-S909/LATS2-S872 Rabbit pAb |
|||
| AP0879-20ul | Abclonal | 20 ul | Ask for price |
phospho-LATS1-S909/LATS2-S872 Rabbit pAb |
|||
| AP0879-50ul | Abclonal | 50 ul | EUR 384 |
phospho-LATS1-T1079/LATS2-T1041 Rabbit pAb |
|||
| AP0880-100ul | Abclonal | 100 ul | Ask for price |
phospho-LATS1-T1079/LATS2-T1041 Rabbit pAb |
|||
| AP0880-200ul | Abclonal | 200 ul | Ask for price |
phospho-LATS1-T1079/LATS2-T1041 Rabbit pAb |
|||
| AP0880-20ul | Abclonal | 20 ul | Ask for price |
phospho-LATS1-T1079/LATS2-T1041 Rabbit pAb |
|||
| AP0880-50ul | Abclonal | 50 ul | EUR 384 |
phospho-LATS1-S909/LATS2-S872 Rabbit pAb |
|||
| AP0904-100ul | Abclonal | 100 ul | EUR 384 |